Ivan Donaldson – Vice President of Investor Relations David V. Goeckeler – Chairman & CEO Luis Visoso – Executive VP & CFO
Advertisement
Conference Call Participants
Mark Newman – Bernstein Institutional Services LLC, Research Division Joseph Moore – Morgan Stanley, Research Division Benjamin Reitzes – Melius Research LLC Christopher Muse – Cantor Fitzgerald & Co., Research Division James Schneider – Goldman Sachs Group, Inc., Research Division Asiya Merchant – Citigroup Inc., Research Division Vijay Rakesh – Mizuho Securities USA LLC, Research Division Blayne Curtis – Jefferies LLC, Research Division Victor Santiago – Evercore ISI Institutional Equities, Research Division Ruplu Bhattacharya – BofA Securities, Research Division
Presentation
Advertisement
Operator
Good afternoon, and welcome to Sandisk’s Third Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Ivan Donaldson, Vice President of Investor Relations. Please go ahead.
Advertisement
Ivan Donaldson Vice President of Investor Relations
Before we begin, please note that today’s discussion will contain forward-looking statements based on management’s current assumptions and expectations, which are subject to various risks and uncertainties. These forward-looking statements, including expectations for our technology and product portfolio, our business plans and performance, our capital allocation priorities, market trends and opportunities and our future financial results. We assume no obligation to update these statements. Please refer to our annual report on Form 10-K and our other filings with the SEC for more information on the risks and uncertainties that could cause actual results to differ materially from expectations.
We will also make references to non-GAAP financial measures today. Reconciliations between the non-GAAP and comparable GAAP financial measures are included in the written materials posted in the Investor Relations section of our website.
BlackRock Global Head of Retirement Solutions Nick Nefouse joins ‘Varney & Co.’ to discuss a proposed rule expanding 401(k)s to crypto and real estate.
President Donald Trump signed an executive order on Thursday to help expand access to retirement savings accounts for Americans who do not have employer-provided plans.
“Beginning at the start of next year, every American will be able to go to TrumpIra.gov and open a new low-cost IRA account,” Trump said in the Oval Office. “You’ll then be able to access the same type of retirement accounts that federal employees enjoy through the Thrift Savings Plans, which are incredible. As part of the Federal Savings Match program, low-income Americans will be eligible to receive up to $1,000 per year in matching funds deposited directly into their accounts.”
Advertisement
“The great thing for millions of Americans who lack employer-sponsored plans, this will be really revolutionary because they’ll be covered,” Trump said. “Nobody thought that was possible. For example, if a 25-year-old who is eligible for a Savers Match program invest just $165 a month under the matching federal contributions, they will have an estimated $465,000 in their account by the time they’re 65 years old. In other words, they’ll be rich. And there’s something awfully nice about that.”
A White House official confirmed the planned order to FOX Business earlier Thursday.
The Trump administration’s effort will work in conjunction with 2022 legislation that instructs the federal government to match retirement-plan contributions for people earning below $35,000 with as much as $1,000 beginning next year,” Semafor reported.
President Donald Trump attends the White House Correspondents’ Association Dinner on April 25, 2026, in Washington, D.C. (Kevin Mazur/Getty Images for OP)
The president’s new order will instruct the Treasury Department to open a TrumpIRA.gov website by the time the matching opportunity takes effect in January, a White House official indicated. Workers will be able to utilize the site to filter private-sector retirement plans based on different factors so they can join one that would enable them to receive the match if qualified.
A picture taken on Dec. 7, 2021 in Istanbul shows U.S. currency. (Ozan Kose/AFP via Getty Images)
The department will screen the plans on the site, but will not team up with certain financial institutions like it did with Trump Accounts, the official noted, according to Semafor.
U.S. President Donald Trump waves to the media after walking off of Air Force One at Miami International Airport on April 11, 2026 in Miami, Fla. (Tasos Katopodis/Getty Images / Getty Images)
The order will instruct the Treasury Department to publicize the match and release information for those in the private sector who wish to give workers’ IRAs, the outlet reported, adding that the White House official compared the concept to the Dells’ pledge to seed Trump Accounts for kids.
Hi. This is Craig Brelsford with RedChip Companies. Thank you for joining us for what promises to be an exciting session with Lantern Pharma. Today’s session is centered around a live real-time demonstration of withZeta.ai, Lantern Pharma’s next-generation AI platform designed to transform how oncology drugs are discovered, particularly in rare cancers. Rather than just talking about the technology, you’ll see it in action, executing research workflows, synthesizing complex scientific data and generating insights in real-time. This is a rare opportunity to observe how AI is being applied at the front lines of drug development.
Lantern Pharma, which trades on the NASDAQ under the ticker LTRN, is positioning this platform not only as a scientific engine, but also as a scalable subscription-based business with meaningful commercial potential.
Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology. We will begin with the presentation and demo momentarily followed by a Q&A session. [Operator Instructions]
Advertisement
Before we begin, please allow me to read the safe harbor statement. This call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements. Any statements that are not historical facts should also be considered forward-looking statements. And of course, forward-looking statements involve risks and uncertainties.
LOS ANGELES — Nearly four weeks after suffering a Grade 2 left hamstring strain, Los Angeles Lakers superstar Luka Doncic continues a cautious rehabilitation protocol focused on controlled on-court movement and progressive loading, with no firm timetable for return as the team battles through its first-round playoff series against the Houston Rockets.
Luka Doncic
The Slovenian guard, who injured his hamstring late in a blowout loss to the Oklahoma City Thunder on April 2, remains listed as out indefinitely. Coach JJ Redick confirmed this week that Doncic has advanced beyond standstill drills to light on-court activity, marking a significant step in his recovery from the partial muscle tear.
Medical experts describe a Grade 2 hamstring strain as involving noticeable fiber disruption without a complete rupture, typically requiring four to six weeks for full recovery. Doncic’s aggressive approach included traveling to Madrid shortly after the injury for specialized regenerative treatments, including platelet-rich plasma and stem cell injections under the care of physicians linked to his former club, Real Madrid.
Those interventions aimed to accelerate healing, potentially compressing the standard timeline. As of late April, sports medicine specialists like Dr. Jesse Morse estimated a possible return window of 10 to 14 days from the point when meaningful on-court movement begins, placing a potential comeback in mid-to-late May if progress holds.
Redick provided the most recent public update, noting Doncic “was able to move today a little bit on the court. Most of the stuff has been standstill. He’s progressing.” The coach stressed there is still no timeline, echoing reports from ESPN’s Shams Charania that the recovery path remains slow. Doncic has not yet progressed to one-on-one work or full-speed scrimmaging.
Advertisement
The protocol follows a standard phased return-to-play model for hamstring injuries in elite athletes. Phase one emphasized protection and controlled mobility, including rest, compression, physical therapy and the European injections. Phase two has introduced light jogging, directional changes and basketball-specific movements at sub-maximal effort. Subsequent phases will incorporate sprinting, jumping, cutting and contact before clearance for game play.
Lakers medical staff monitor metrics such as muscle strength symmetry, flexibility and pain-free range of motion. Hamstring strains carry high re-injury risk — often 20-30% in professional sports — if athletes return prematurely, particularly in a high-usage player like Doncic who relies on explosive first steps and deceleration.
Doncic rejoined the team in Los Angeles ahead of the playoffs but has not traveled with the squad for road games against Houston. His presence on the bench has provided intangible leadership, yet the Lakers have leaned heavily on LeBron James, Austin Reaves (also recovering from an oblique strain) and supporting cast members.
Expectations point to Doncic missing the entire first-round series. Even if the Lakers advance, multiple reports indicate he is unlikely to be available for the start of the Western Conference semifinals, with a more realistic target around Games 3 or 4 of a potential second-round matchup. Six weeks from the April 2 injury date would land in mid-May.
Advertisement
The injury occurred at a critical juncture. Doncic had been playing at an MVP-caliber level, powering the Lakers to a strong late-season surge. His absence has reshaped playoff dynamics in the Western Conference, forcing Los Angeles to adapt without its primary playmaker and leading scorer.
Team officials and medical experts weigh the long-term risks against short-term playoff ambitions. Rushing a return could jeopardize Doncic’s availability for future seasons or lead to chronic issues. Hamstring injuries have historically sidelined stars for extended periods, with re-aggravation often extending timelines significantly.
Doncic’s work ethic and competitive drive have been highlighted throughout the process. Sources describe him attacking rehab aggressively while remaining in good spirits. His agent, Bill Duffy, confirmed the European trip was a collaborative decision involving Lakers doctors and independent specialists.
Broader implications extend to the Lakers’ roster construction and future planning. The team traded for Doncic earlier in the season in a blockbuster move, banking on his superstar talent to elevate the franchise. His prolonged absence tests depth and underscores the fragility of championship contention when key pieces go down.
Advertisement
Fans and analysts track every update closely. Social media buzzes with speculation about potential return dates, fueled by optimistic interpretations of practice footage and vague coaching comments. Yet insiders maintain patience is essential.
For a 27-year-old in his prime, full recovery remains highly probable with proper management. Modern sports medicine, including the biologics Doncic received, has improved outcomes for soft-tissue injuries. Strength and conditioning programs tailored to basketball movements will play a pivotal role in the final rehab stages.
As the Lakers navigate the playoffs without their All-NBA talent, focus shifts to collective resilience. James has shouldered a heavier load, while younger players step into expanded roles. A deep run without Doncic would be impressive; his eventual return could provide a massive boost for later rounds.
Looking ahead, the Lakers’ medical staff will continue daily assessments. Progression to non-contact 3-on-3 or 5-on-5 work will signal the next major milestone. Only after clearing sport-specific testing, including sprint times and change-of-direction drills, will Doncic receive medical clearance.
Advertisement
The organization emphasizes a conservative approach. “We’re going to do what’s best for Luka long-term,” Redick has reiterated in various forms. That philosophy prioritizes sustainable health over rushed availability.
Doncic’s injury serves as a reminder of basketball’s physical demands. Even superstars face setbacks, and recovery protocols balance science, patience and individual response. For now, the focus remains on incremental gains — more fluid movement, greater confidence in the hamstring and steady buildup toward basketball activities.
Whether Doncic returns this postseason or begins the 2026-27 season fully healthy, his current protocol reflects best practices in elite athlete care. The basketball world watches, hoping the star’s dedication yields a strong comeback when the moment is right.
You must be logged in to post a comment Login